Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Vascular Ehlers-Danlos Syndrome Diagnosed in a Patient Initiating Hemodialysis.

ABSTRACT:

SUBMITTER: Ouchi H

PROVIDER: S-EPMC6933463 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Vascular Ehlers-Danlos Syndrome Diagnosed in a Patient Initiating Hemodialysis.

Ouchi Haruki H Nishi Hiroshi H Nakamura Motonobu M Hirakawa Yosuke Y Tanaka Tetsuhiro T Takeda Norifumi N Akai Takafumi T Ohashi Yuichi Y Hoshina Katsuyuki K Takayama Toshio T Nangaku Masaomi M

Kidney international reports 20190808 11

PMID: 31891008

Similar Datasets

Spinal Anaesthesia for Cesarean Section in a Patient with Vascular Type Ehlers-Danlos Syndrome.

Project description: Not available

| S-EPMC5829370 | biostudies-literature

Steroid Hormone Dependent Pathogenesis in Vascular Ehlers-Danlos Syndrome

Project description:Vascular Ehlers-Danlos Syndrome (VEDS) is a genetic connective tissue disorder caused by heterozygous mutations in the COL3A1 gene encoding type III collagen which result in spontaneous rupture of the arteries, intestines, and gravid uterus. Aortic ruptures occur primarily in the descending thoracic aorta. Male VEDS patients experience a higher rate of catastrophic vascular events (dissections or ruptures) during puberty compared to females suggesting a role for androgens. Our Col3a1G938D/+ mouse model recapitulates the sexually dimorphic phenotype of spontaneous death due to aortic rupture in puberty. Our work with VEDS mice subjected to androgen receptor inhibition, through the use of a conditional allele for the androgen receptor (AR) to generate global Ar null mice or through the use of pharmacologic AR antagonism with bicalutamide, discovered that androgens drive sexual dimorphic survival. We also found a role for mineralocorticoid receptor signaling with the use of spironolactone, a dual AR and MR antagonist, and finerenone, a specific MR antagonist. Therefore, we employed single nucleus-RNAseq of the descending thoracic aorta to identify the molecular mechanism driving AR, MR, and dual AR/MR protection in VEDS male mice. We discovered AR or MR antagonism normalized expression of dysregulated transcripts in both VEDS endothelial cells (ECs) and vascular smooth muscle cells (VSMCs). In ECs, components of cell junctions and modulators of cell junction stability were dysregulated while transcripts encoding a contractile VSMC phenotype, integrin signaling, and focal adhesions were modulated in VSMCs.

2026-03-17 | GSE288058 | GEO

Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.

Project description: Not available

| S-EPMC6994142 | biostudies-literature

Varied Presentations of Arterial Events in Vascular Ehlers-Danlos Syndrome.

Project description: Not available

| S-EPMC12793884 | biostudies-literature

Multiple Dermatomyofibromas in a Patient with Ehlers-Danlos Syndrome.

Project description: Not available

| S-EPMC10294281 | biostudies-literature

Open repair of an infected abdominal aortic aneurysm in a patient with vascular Ehlers-Danlos syndrome

Project description: Not available